Data as of Q4 2025 (Dec 31, 2025)

First Light Asset Management, LLC

โ€ขCIK: 1600004โ€ขFiling: Q4 2025

**First Light Asset Management, LLC** manages $1.3B across a focused portfolio of 33 positions. The fund exhibits significant conviction in select names, with its top holding in AXGN commanding $171.3M. Further concentration is evident in NEO ($118.0M) and SIBN ($99.2M), suggesting a deep-value or thematic allocation strategy. This structure indicates a concentrated, high-conviction approach to generating alpha.

Total AUM
$1.3B
QoQ Performance
+23.3%
Positions
33
Top 10 Concentration
57.2%
Latest Filing
Q4 2025

Top Holdings Allocation

AXGN
NEO
SIBN
PVLA
AXGN13.1%
NEO9.0%
SIBN7.6%
PVLA5.7%
CNTA4.4%
CRNX4.3%
ATRC3.6%
VERA3.4%

๐Ÿ“ˆ Biggest Buys

SIBN
SI-BONE INC
+162.4%
7.6% of portfolio
MDGL
MADRIGAL PHARMACEUTICALS INC
+479.2%
3.0% of portfolio
WVE
WAVE LIFE SCIENCES LTD
NEW
2.4% of portfolio
TNDM
TANDEM DIABETES CARE INC
NEW
1.8% of portfolio
IRON
DISC MEDICINE INC
+126.3%
3.2% of portfolio

๐Ÿ“‰ Biggest Sells

CNTA
CENTESSA PHARMACEUTICALS LIMITED
-37.3%
4.4% of portfolio
ORGO
ORGANOGENESIS HOLDINGS INC
-48.5%
1.5% of portfolio
AXGN
AXOGEN INC
-9.9%
13.1% of portfolio
ANAB
ANAPTYS BIO INC
-34.7%
2.4% of portfolio
MDXG
MIMEDX GROUP INC
-16.8%
1.6% of portfolio

Sector Breakdown

Other100.0%

๐Ÿšช Exited Positionssold since Q3 2025

โ€”
PERFORMANT HEALTHCARE INC
SOLD
$90.6M
LENZ
LENZ THERAPEUTICS INC
SOLD
$32.3M
CDTX
CIDARA THERAPEUTICS INC
SOLD
$28.0M
2GH
MERUS NV
SOLD
$21.1M
ADMA
ADMA BIOLOGICS INC
SOLD
$15.7M
+9 more exited positions

Changes from Q3 2025

NEW6 new positions
โ†‘14 increased
โ†“13 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023